top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights
Search

ElevateBio Secures $401M Series D Financing, Spearheading Advancements in Cell and Gene Therapies

  • May 24, 2023
  • 1 min read

Waltham, MA, May 24, 2023 (Business Wire) -- ElevateBio, a leading company focused on cell and gene therapies, has successfully closed a Series D financing round, raising $401 million. The funds will fuel the expansion of ElevateBio's advanced technology platforms, including gene editing and induced pluripotent stem cells (iPSCs), and support the development of an extensive pipeline of transformative therapies.


Read full article here.

 
 
 

Recent Posts

See All
Qlaris Bio Appoints Fred Guerard as CEO

Dedham, MA, March 1, 2026 (Business Wire) -- Qlaris Bio has appointed Fred Guerard, Pharm.D., as president and chief executive officer, effective March 1, 2026, and he will also join the company’s b

 
 
 

Comments

Life Science Headlines
bottom of page